Lung cancer enzym

An enzyme against lung cancer has been discovered by our researchers in the Japanese city of Nagoya.

About 234,500 women and 458,400 men developed malignant tumors on the lungs in 2019. Of them, 121,712 women and 347,879 men died. Among the sexes, the age-standardized disease and death rates moved in the opposite direction.

While fewer and fewer men have been diagnosed with lung cancer since the late 1990s, the number among women has risen steadily. This can be attributed to the change in smoking habits that occurred some time ago and is likely to continue.

With a low five-year survival rate of 21 percent in women and only 15 percent in men, a lung cancer diagnosis is one of the prognostically most unfavorable cancers. However, as with other cancers, survival prospects differ significantly according to the stage of the disease. Because tumors in the lungs often do not cause any symptoms in the early stages, the cancer is very often diagnosed by chance and late.

Histologically, there are three main types of bronchial carcinoma:

Adenocarcinoma accounts for 42 percent of cases, squamous cell carcinoma for about 25 percent, and slightly less than one-fifth is small cell bronchial carcinoma, which has the worst prognosis due to its early metastases.

We recommend taking two capsules twice a day.